{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:24:11Z","timestamp":1760984651759},"publisher-location":"Berlin, Heidelberg","reference-count":20,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642316289"},{"type":"electronic","value":"9783642316296"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-3-642-31629-6_7","type":"book-chapter","created":{"date-parts":[[2012,11,5]],"date-time":"2012-11-05T03:11:17Z","timestamp":1352085077000},"page":"107-113","source":"Crossref","is-referenced-by-count":11,"title":["Adenocarcinoma Of the GEJ: Gastric or Oesophageal Cancer?"],"prefix":"10.1007","author":[{"given":"J.","family":"R\u00fcschoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,6]]},"reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, R\u00fcschoff J, Kang YK (2010) ToGA Trial Investigators Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687\u2013697","journal-title":"Lancet"},{"key":"7_CR2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00292-011-1541-0","volume":"33","author":"GB Baretton","year":"2012","unstructured":"Baretton GB, Aust DE (2012) Barrett-\u00f6sophagus. Aktueller Stand Pathologe 33:5\u201316","journal-title":"Aktueller Stand Pathologe"},{"key":"7_CR3","volume-title":"WHO classification of tumours of the digestive system","author":"FT Bosman","year":"2010","unstructured":"Bosman FT, Carneiro F, Hruban RH, Theise ND (2010) WHO classification of tumours of the digestive system. IARC, Lyon"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/modpathol.2010.59","volume":"23","author":"IS Brown","year":"2010","unstructured":"Brown IS, Whiteman DC, Lauwers GY (2010) Foveolar type dysplasia in Barrett esophagus. Mod Pathol 23:834\u2013843","journal-title":"Mod Pathol"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PAS.0b013e31822a5a2c","volume":"36","author":"P Chandrasoma","year":"2012","unstructured":"Chandrasoma P, Wijetunge S, DeMeester S, Ma Y, Hagen J, Zamis L, DeMeester T (2012) Columnar-lined esophagus without intestinal metaplasia has no proven risk of adenocarcinoma. Am J Surg Pathol 36:1\u20137","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"7_CR6","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/modpathol.2011.77","volume":"24","author":"EG Demicco","year":"2011","unstructured":"Demicco EG, Farris AB 3rd, Baba Y, Agbor-Etang B, Bergethon K, Mandal R, Daives D, Fukuoka J, Shimizu M, Dias-Santagata D, Ogino S, Iafrate AJ, Gaissert HA, Mino-Kenudson M (2011) The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma. Mod Pathol 24(9):1177\u20131190","journal-title":"Mod Pathol"},{"key":"7_CR7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/sj.bjc.6604861","volume":"100","author":"SW Han","year":"2009","unstructured":"Han SW, Oh DY, Im SA, Park SR, Lee KW, Song HS, Lee NS, Lee KH, Choi IS, Lee MH, Kim MA, Kim WH, Bang YJ, Kim TY (2009) Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer. Br J Cancer 100:298\u2013304","journal-title":"Br J Cancer"},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","volume":"365","author":"F Hvid-Jensen","year":"2011","unstructured":"Hvid-Jensen F, Pedersen L, Drewes AM, S\u00f8rensen HT, Funch-Jensen P (2011) Incidence of adenocarcinoma among patients with Barrett\u2019s esophagus. N Engl J Med 365:1375\u20131383","journal-title":"N Engl J Med"},{"key":"7_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1365-2559.2008.03028.x","volume":"52","author":"M Hofmann","year":"2008","unstructured":"Hofmann M, Stoss O, Shi D, B\u00fcttner R, van de Vijver M, Kim W, Ochiai A, R\u00fcschoff J, Henkel T (2008) Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology 52:797\u2013805","journal-title":"Histopathology"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3109\/00365521.2011.565069","volume":"46","author":"T Horii","year":"2011","unstructured":"Horii T, Koike T, Abe Y, Kikuchi R, Unakami H, Iijima K, Imatani A, Ohara S, Shimosegawa T (2011) Two distinct types of cancer of different origin may be mixed in gastroesophageal junction adenocarcinomas in Japan: evidence from direct evaluation of gastric acid secretion. Scand J Gastroenterol 46:710\u2013719","journal-title":"Scand J Gastroenterol"},{"key":"7_CR11","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJMe1108435","volume":"365","author":"PJ Kahrilas","year":"2011","unstructured":"Kahrilas PJ (2011) The problems with surveillance with Barrett\u00b4s esophagus. N Engl J Med 365:1437\u20131438","journal-title":"N Engl J Med"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/PAS.0b013e31823d08d6","volume":"36","author":"TS Khor","year":"2012","unstructured":"Khor TS, Alfaro EE, Ooi EM, Li Y, Srivastava A, Fujita H, Park Y, Kumarasinghe MP, Lauwers GY (2012) Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus? Am J Surg Pathol 36:331\u2013342","journal-title":"Am J Surg Pathol"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1365-2559.2010.03643.x","volume":"57","author":"AH Marx","year":"2010","unstructured":"Marx AH, Zielinski M, Kowitz CM, Dancau AM, Thieltges S, Simon R, Choschzick M, Yekebas E, Kaifi JT, Mirlacher M, Atanackovic D, Br\u00fcmmendorf TH, Fiedler W, Bokemeyer C, Izbicki JR, Sauter G (2010) Homogeneous EGFR amplification defines a subset of aggressive Barrett\u2019s adenocarcinomas with poor prognosis. Histopathology 57:418\u2013426","journal-title":"Histopathology"},{"key":"7_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/jnci\/dji024","volume":"97","author":"H Pohl","year":"2005","unstructured":"Pohl H, Welch G (2005) The role of over diagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97:142\u2013146","journal-title":"J Natl Cancer Inst"},{"key":"7_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.198","author":"J R\u00fcschoff","year":"2012","unstructured":"R\u00fcschoff J, Hanna W, Bilous M, Hofmann M, Osamura RY, Penault-Llorca F, van de Vijver M, Viale G (2012) HER2 testing in gastric cancer: a practical approach. Mod Pathol 25:637\u2013650","journal-title":"Mod Pathol"},{"key":"7_CR16","doi-asserted-by":"crossref","unstructured":"Siewert JR, Stein HJ, Lordick F (2006) \u00d6sophaguskarzinom. In Siewert JR, Rothmund M, Schumpelick V (eds) Praxis der viszeralchirurgie. Springer, Heidelberg","DOI":"10.1007\/3-540-30036-8"},{"key":"7_CR17","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/jcp.2009.066548","volume":"62","author":"M Varella-Garcia","year":"2009","unstructured":"Varella-Garcia M, Diebold J, Eberhard DA, Geenen K, Hirschmann A, Kockx M, Nagelmeier I, R\u00fcschoff J, Schmitt M, Arbogast S, Cappuzzo F (2009) EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer. J Clin Pathol 62:970\u2013977","journal-title":"J Clin Pathol"},{"key":"7_CR18","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1097\/PAS.0b013e3181eff133","volume":"34","author":"S Wijetunge","year":"2010","unstructured":"Wijetunge S, Ma Y, DeMeester S, Hagen J, DeMeester T, Chandrasoma P (2010) Association of adenocarcinomas of the distal esophagus, \u201cgastroesophageal junction,\u201d and \u201cgastric cardia\u201d with gastric pathology. Am J Surg Pathol 34:1521\u20131527","journal-title":"Am J Surg Pathol"},{"key":"7_CR19","unstructured":"Wittekind C, Meyer H-J (2010) TNM Klassifikation maligner Tumoren 7. Auflage. Wiley-VHC, Weinheim"},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1158\/1078-0432.CCR-11-2272","volume":"18","author":"HH Yoon","year":"2012","unstructured":"Yoon HH, Shi Q, Sukov WR, Wiktor AE, Khan M, Sattler CA, Grothey A, Wu TT, Diasio RB, Jenkins RB, Sinicrope FA (2012) Association of HER2\/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas. Clin Cancer Res 18:546\u2013554","journal-title":"Clin Cancer Res"}],"container-title":["Recent Results in Cancer Research","Early Gastrointestinal Cancers"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-31629-6_7.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T07:40:53Z","timestamp":1620114053000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-31629-6_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9783642316289","9783642316296"],"references-count":20,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-31629-6_7","relation":{},"ISSN":["0080-0015"],"issn-type":[{"type":"print","value":"0080-0015"}],"subject":[],"published":{"date-parts":[[2012]]}}}